Search Within

Gary Schwartz

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (9)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (19)
  2. Sloan Kettering Institute Faculty (19)
  3. GSK Faculty (15)
  4. Department of Medicine (10)
  5. Solid Tumor Oncology Division (9)
  6. Population Sciences Research Program (8)

More Groups

People
  1. Yueming Li (6)
  2. Christopher Shelton (5)
  3. Raymond Meng (5)
  4. David Kelsen (4)
  5. Murray Brennan (4)
  6. David Solit (3)

More People

Years
  1. 2013 (2)
  2. 2011 (2)
  3. 2009 (2)
  4. 2008 (1)
  5. 2007 (2)
  6. 2006 (2)

More Years

Publications
  1. Cancer Research (7)
  2. Journal of Clinical Oncology (4)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (1)
  5. Cancer (1)
  6. Gastroenterology (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (4)
  3. Oxford University Press (2)
  4. Elsevier Inc. (1)
  5. Wiley Blackwell (1)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • PTEN is a critical determinant in sensitizing cells to gamma-secretase inhibitors
    Meeting Abstract

    Nair, J. S.; Sheikh, T. N.; Li, Y. M.; Schwartz, G. K.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Imaging colon cancer response following treatment with AZD1152: A preclinical analysis of [18F]fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]fluorothymidine imaging
    Journal Article

    Moroz, M. A.; Kochetkov, T.; Cai, S.; Wu, J.; Shamis, M.; Nair, J.; de Stanchina, E.; Serganova, I.; Schwartz, G. K.; Banerjee, D.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Suppression of notch signaling with gamma-secretase inhibitors sensitizes malignant peripheral nerve sheath tumors to inhibitors of the Ras/Raf and PI3K/Akt pathways
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y.; Schwartz, G. K.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity
    Journal Article

    Meng, R. D.; Shelton, C. C.; Li, Y. M.; Qin, L. X.; Notterman, D.; Paty, P. B.; Schwartz, G. K.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dual inhibition of the Notch and Hedgehog developmental pathways in colon cancers suppresses viability by combined downregulation of the PI3K/Akt pathway
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y. M.; Schwartz, G. K.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Gamma-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Cheema, H. S.; Li, Y.; Schwartz, G. K.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
    Journal Article

    Guo, T.; Agaram, N. P.; Wong, G. C.; Hom, G.; D'adamo, D.; Maki, R. G.; Schwartz, G. K.; Veach, D.; Clarkson, B. D; Singer, S.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Disrupting the notch pathway with gamma-secretase inhibitors suppresses growth and induces apoptosis of sarcoma cell lines with constitutively active ras and notch signaling pathways
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y.; Schwartz, G. K.
    Cancer Research (2006)

    Fulltext@MSK | Save